Načítá se...
2-Oxoamide inhibitors of cytosolic group IVA phospholipase A(2) with reduced lipophilicity
Cytosolic GIVA phospholipase A(2) (GIVA cPLA(2)) initiates the eicosanoid pathway of inflammation and thus inhibitors of this enzyme constitute novel potential agents for the treatment of inflammatory diseases. Traditionally, GIVA cPLA(2) inhibitors have suffered systemically from high lipophilicity...
Uloženo v:
| Vydáno v: | Bioorg Med Chem |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5014611/ https://ncbi.nlm.nih.gov/pubmed/27522578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.07.057 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|